![]() |
Prostate Cancer |
Free Subscription
1 Am J Surg Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Genitourinary Pathology Society and International Society of Urological Pathology
White Paper on Defining Indolent Prostate Cancer.
Am J Surg Pathol. 2025 May 30. doi: 10.1097/PAS.0000000000002425.
PubMed
Abstract available
Prostate cancer: detection, treatment and follow-up.
BJU Int. 2025;136:2-3.
PubMed
Incidence, surveillance and natural history of high-grade prostatic epithelial
neoplasia in the era of multiparametric MRI and targeted biopsy.
BJU Int. 2025;136:159-164.
PubMed
Abstract available
Transperineal prostate biopsy under local vs general anaesthesia: a
cost-effectiveness analysis.
BJU Int. 2025;136:128-134.
PubMed
Abstract available
Positive surgical margin and oncological outcomes after robot-assisted radical
prostatectomy in different Cancer of the Prostate Risk Assessment risk groups.
BJU Int. 2025;136:135-142.
PubMed
Abstract available
CpG dinucleotide methylation of the SPDEF gene as a blood-based epigenetic
biomarker for prostate cancer diagnosis.
BMC Urol. 2025;25:145.
PubMed
Abstract available
Prognostic factors of biochemical recurrence and impact of pre-treatment MRI for
prostate cancer radiotherapy.
Br J Radiol. 2025 Jun 2:tqaf122. doi: 10.1093.
PubMed
Abstract available
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto
Briganti's Letter to the Editor re: Andreas Josefsson, Marianne Mansson, Kimia
Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific
Antigen in th
Eur Urol. 2025;87:e112-e113.
PubMed
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in
Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150
Trial.
Eur Urol. 2025;87:672-682.
PubMed
Abstract available
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic
and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial.
Eur Urol. 2025 Jun 2:S0302-2838(25)00298-2. doi: 10.1016/j.eururo.2025.
PubMed
Abstract available
Evaluating the Safety of Delaying Surgery Beyond 9 Months in Localized Prostate
Cancer Patients: Results From a Prospective Study With Propensity Score Matching.
Int J Urol. 2025 Jun 4. doi: 10.1111/iju.70142.
PubMed
Abstract available
VIRMA Accelerates the Tumorigenesis of Prostate Cancer via Regulating the m(6)A
Modification of NSMCE2 to Eliminate the Generation of Reactive Oxygen Species.
Int J Urol. 2025 Jun 3. doi: 10.1111/iju.70140.
PubMed
Abstract available
Significance of Inflammation Markers to Predict Curative Treatment for Prostate
Cancer Patients on Active Surveillance.
J Clin Lab Anal. 2025 May 31:e70059. doi: 10.1002/jcla.70059.
PubMed
Abstract available
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human
Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase 1
Study.
J Clin Oncol. 2025 Jun 1:101200JCO2500678. doi: 10.1200/JCO-25-00678.
PubMed
Abstract available
Utilizing peer educators to increase genetic testing for prostate cancer among
black males: results of a randomized controlled trial.
J Natl Med Assoc. 2025 May 29:S0027-9684(25)00040.
PubMed
Abstract available
Efficacy, Safety, Blood Kinetics, and (213)Bi Distribution Studies of
[(225)Ac]Ac-SibuDAB in Prostate Cancer Patients.
J Nucl Med. 2025 Jun 5:jnumed.125.269655. doi: 10.2967/jnumed.125.269655.
PubMed
Abstract available
Imaging Efficacy of [(18)F]CTT1057 PET/CT in Patients with Biochemically
Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective
Multicenter Study.
J Nucl Med. 2025 Jun 5:jnumed.124.269266. doi: 10.2967/jnumed.124.269266.
PubMed
Abstract available
Treatment Response Evaluation in Prostate Cancer Using PSMA PET/CT.
J Nucl Med. 2025 Jun 5:jnumed.124.268071. doi: 10.2967/jnumed.124.268071.
PubMed
Abstract available
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted
Radiopharmaceutical Therapy.
J Nucl Med. 2025 Feb 27:jnumed.124.268818. doi: 10.2967/jnumed.124.268818.
PubMed
Abstract available
Editorial Comment on: "Restriction Spectrum Imaging as a Quantitative Biomarker
for Prostate Cancer with Reliable Positive Predictive Value".
J Urol. 2025 Jun 4:101097JU0000000000004620. doi: 10.1097/JU.0000000000004620.
PubMed
Editorial Comment: Restriction Spectrum Imaging as a Quantitative Biomarker for
Prostate Cancer with Reliable Positive Predictive Value.
J Urol. 2025 Jun 4:101097JU0000000000004621. doi: 10.1097/JU.0000000000004621.
PubMed
Longitudinal quantitative MRI in prostate cancer after radiation therapy with and
without androgen deprivation therapy.
Magn Reson Imaging. 2025;122:110431.
PubMed
Abstract available
Accelerating prostate rs-EPI DWI with deep learning: Halving scan time, enhancing
image quality, and validating in vivo.
Magn Reson Imaging. 2025;121:110418.
PubMed
Abstract available
A hormone-dependent tRNA half promotes cell cycle progression via destabilization
of p21 mRNA.
PLoS Biol. 2025;23:e3003194.
PubMed
Abstract available
Retraction: Evidence for a Pro-proliferative Feedback Loop in Prostate Cancer:
The role of Epac1 and COX-2-dependent Pathways.
PLoS One. 2025;20:e0325680.
PubMed
Retraction: Receptor-Recognized alpha2-Macroglobulin Binds to Cell Surface-Associated
GRP78 and Activates mTORC1 and mTORC2 Signaling in Prostate Cancer Cells.
PLoS One. 2025;20:e0325675.
PubMed
Towards robust medical machine olfaction: Debiasing GC-MS data enhances prostate
cancer diagnosis from urine volatiles.
PLoS One. 2025;20:e0314742.
PubMed
Abstract available
Costs of non-metastatic prostate cancer treatment among privately insured men in
the United States.
PLoS One. 2025;20:e0324902.
PubMed
Abstract available
BRCA2 reversion mutation-independent resistance to PARP inhibition through
impaired DNA prereplication complex function.
Proc Natl Acad Sci U S A. 2025;122:e2426743122.
PubMed
Abstract available
The TRANSLATE Trial: Transrectal versus Transperineal Biopsy for Prostate Cancer
Detection.
Radiol Imaging Cancer. 2025;7:e259010.
PubMed
Deep Learning-based Anatomy-Aware Morph Model for Registration of Prostate
Whole-Mount Histopathology to MRI.
Radiol Imaging Cancer. 2025;7:e240336.
PubMed
Abstract available
Topic Mapping to Inform Content to Discuss in Shared Decision-Making for Prostate
Cancer.
Urology. 2025 May 28:S0090-4295(25)00511-4. doi: 10.1016/j.urology.2025.
PubMed
Abstract available
Thank you for your interest in scientific medicine.